Redondo-Castro, ElenaCunningham, CatrionaMiller, JonjoMartuscelli, LiciaAoulad-Ali, SarahRothwell, Nancy J.Kielty, Cay M.Allan, Stuart M.Pinteaux, Emmanuel2020-05-202020-05-202017-04-17Redondo-Castro, E, Cunningham, C, Miller, J, Martuscelli, L, Aoulad-Ali, S, Rothwell, N J, Kielty, C M, Allan, S M & Pinteaux, E 2017, 'Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro', Stem cell research & therapy, vol. 8, 79. https://doi.org/10.1186/s13287-017-0531-41757-6512ORCID: /0000-0002-9216-9414/work/35739934https://hdl.handle.net/2164/14336The authors would like to acknowledge the assistance of Rebecca Holley (Wellcome Trust Centre for Cell-Matrix Research, UK Centre for Tissue Engineering) and Gareth Howell (Flow Cytometry Facility within the Manchester Collaborative Centre for Inflammation Research). They thank Swedish Orphan Biovitrum AB for providing the Kineret® used in these studies. The work was supported by funds from the Stroke Association (UK), the Engineering and Physical Sciences Research Council (EPSRC), the Medical Research Council (MRC), the Centre for Doctoral Training in Regenerative Medicine studentship grant EP/L014904/1 and the Manchester Regenerative Medicine Network (MaRM).111057328engSDG 3 - Good Health and Well-beingStrokeHuman mesenchymal stem cellsCytokinesPrimingBone marrow-derived stromal cellsInterleukin-1R MedicineEngineering and Physical Sciences Research Council (EPSRC)EP/L014904/1Medical Research Council (MRC)EP/L014904/1Supplementary DataRJournal article10.1186/s13287-017-0531-48